Search | Page 18 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Acute Myeloid Leukemia (AML)

    ... chemotherapy drugs. Drugs such as decitabine or azacitidine or hydroxyurea may be better tolerated by older patients. ...

    Topic section last updated 07/07/2016 - 3:15pm.

  2. Identification of genetic abnormalities in MDS patients that may lead to a better diagnosis and treatment strategy of MDS patients

    ... proportion of MDS patients that responded favorable to azacitidine was much higher (nearly twice as high) in the group of patients ...

    Research Review last updated 05/02/2016 - 9:23am.

  3. Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.

    ... chemotherapy or lymphoma chemotherapy or azacitidine or decitabine or tyrosine kinase inhibitor. ... Receipt of at least one cycle of cytotoxic chemotherapy, azacitidine or decitabine. MDS patients must have < or = to 5% bone ...

    Clinical Trial last updated 04/29/2016 - 3:51pm.

  4. Clofarabine in the treatment of myelodysplastic syndromes

    ... DNA methyltransferase inhibitors, such as azacitidine and decitabine , are standard of care for patients with ...

    Research Review last updated 05/02/2016 - 9:18am.

  5. Prognostic Relevance of the Kinetics of Worsening of Cytopenias in Lower-Risk MDS: A Substudy from the European Leukemianet Low Risk MDS (EUMDS) Registry

    ... treated with a hypomethylating agent (such as Vidaza® [ azacitidine ] or Dacogen® [ decitabine ]), a granulocyte ...

    Research Review last updated 05/02/2016 - 9:27am.

  6. Shyamala Navada, MD

    ... investigator of a clinical trial combining azacitidine and rigosertib in MDS patients that will soon be opening at ...

    Bio last updated 03/11/2016 - 1:41pm.

  7. Amer Zeidan, M.D.

    ... MDS who did not respond to the existing drugs (such as azacitidine and decitabine ) and are not candidates for stem cell ...

    Bio last updated 03/11/2016 - 1:41pm.

  8. Incidence and Burden of the Myelodysplastic Syndromes

    ... receive active therapies even though treatments such as azacitidine and lenalidomide have been shown to decrease red ... to or relapse after therapy with hypomethlating agents (azacitidine and decitabine ) carry a poor prognosis.  These patients ...

    Research Review last updated 05/02/2016 - 9:11am.

  9. PRO#1278: Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation (FLUBUTBI)

    ... exception of lenalidomide , decitabine , azacitidine , imatinib mesylate, dasatinib, nilotinib hydrochloride and ...

    Clinical Trial last updated 04/29/2016 - 3:09pm.

  10. Biting into the Elephant

    ... hope in my physician. We formulated our plan which was azacitidine (Vidaza®) treatment followed by a stem cell transplant ...

    Patient Chronicle last updated 06/27/2016 - 2:22pm.